tiprankstipranks
Trending News
More News >
Plus Therapeutics files to sell 1.57B shares of common stock for holders
PremiumThe FlyPlus Therapeutics files to sell 1.57B shares of common stock for holders
29d ago
Promising Outlook for Plus Therapeutics: Buy Rating Affirmed Amid Clinical and Financial Advancements
Premium
Ratings
Promising Outlook for Plus Therapeutics: Buy Rating Affirmed Amid Clinical and Financial Advancements
1M ago
Plus Therapeutics’ Optimistic Earnings Call Highlights
Premium
Company Announcements
Plus Therapeutics’ Optimistic Earnings Call Highlights
1M ago
Plus Therapeutics initiated with a Buy at D. Boral Capital
PremiumThe FlyPlus Therapeutics initiated with a Buy at D. Boral Capital
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Plus regains compliance with Nasdaq minimum stockholders’ equity requirement
Premium
The Fly
Plus regains compliance with Nasdaq minimum stockholders’ equity requirement
2M ago
Plus Therapeutics advances Rhenium Obisbemeda
PremiumThe FlyPlus Therapeutics advances Rhenium Obisbemeda
2M ago
Plus Therapeutics appoints Russell Bradley as president, CNSide
Premium
The Fly
Plus Therapeutics appoints Russell Bradley as president, CNSide
2M ago
Plus Therapeutics apoints Michael Rosol as Chief Development Officer
Premium
The Fly
Plus Therapeutics apoints Michael Rosol as Chief Development Officer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100